10x Genomics TXG reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
10x Genomics missed estimated earnings by 46.15%, reporting an EPS of $-0.57 versus an estimate of $-0.39.
Revenue was down $1.23 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.07 which was followed by a 3.96% drop in the share price the next day.
Here's a look at 10x Genomics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.09 | -0.20 | -0.26 |
| EPS Actual | -0.38 | -0.16 | -0.15 | -0.10 |
| Revenue Estimate | 113.34M | 148.53M | 122.62M | 112.85M |
| Revenue Actual | 114.50M | 143.53M | 125.30M | 115.84M |
To track all earnings releases for 10x Genomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
